MadMonkey42

FibroGenesis (FGEN) is about to pop from COVID-19 news

Long
NASDAQ:FGEN   FibroGen, Inc
There is some great news in regards to a recent announcement about FibroGenesis (FGEN)'s pre-clinical trial using fibroblast cell therapy.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.